Et al., 2010). To improve the pharmacokinetic profile (Poirier et al., 2012), a pegylated anti-CD28
Et al., 2010). To improve the pharmacokinetic profile (Poirier et al., 2012), a pegylated anti-CD28 SCFV named FR104, which was derived from the antiCD28 mAb clone, was created. The pegylated…